All In Biotech

Free tool

FAERS Monitor: Miacalcin

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 017808 or its brand name (Miacalcin, Calcitonin Salmon). Reports on generic versions are filed under their own applications.

Reports

3,123

Serious

2,212

71% of reports

Hospitalization

998

Death reported

279

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • nausea253
  • drug ineffective249
  • fall221
  • pain213
  • arthralgia189
  • dizziness184
  • headache178
  • back pain173
  • dyspnoea164
  • asthenia156
  • fatigue156
  • diarrhoea146
  • pain in extremity146
  • vomiting137
  • pneumonia107

Reports by year received

View as table
YearReports
2004429
2005335
2006243
2007144
2008152
2009150
2010176
2011176
2012212
201363
201465
2015142
2016112
2017108
201881
201991
202055
202139
202273
202381
202473
202579
202644

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,036 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
back painSignal1735.04.3558
fallSignal2214.53.9602
pain in extremitySignal1463.32.8240
arthralgiaSignal1893.12.7266
astheniaSignal1562.82.4181
dizzinessSignal1842.52.2166
painSignal2132.32.1166
pneumoniaSignal1072.21.872
nauseaSignal2532.21.9161
vomiting1372.01.765
dyspnoea1642.01.777
headache1781.91.779
diarrhoea1461.51.327
fatigue1561.31.214
drug ineffective2491.31.115

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.